View Future GrowthMaking Science Group 과거 순이익 실적과거 기준 점검 0/6Making Science Group 의 수입은 연평균 -30.8%의 비율로 감소해 온 반면, Media 산업은 연평균 6%의 비율로 증가했습니다. 매출은 연평균 26.6%의 비율로 증가해 왔습니다.핵심 정보-30.80%순이익 성장률23.10%주당순이익(EPS) 성장률Media 산업 성장률-2.36%매출 성장률26.65%자기자본이익률-17.07%순이익률-2.23%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Oct 24Second quarter 2023 earnings releasedSecond quarter 2023 results: €0.12 loss per share. Revenue: €57.0m (up 15% from 2Q 2022). Net loss: €1.03m (loss widened 35% from 2Q 2022).Reported Earnings • Apr 20Full year 2022 earnings releasedFull year 2022 results: Revenue: €213.4m (up 89% from FY 2021). Net loss: €4.99m (loss widened 43% from FY 2021).Reported Earnings • Apr 17Full year 2020 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €58.9m (up 130% from FY 2019). Net income: €1.54m (up 302% from FY 2019). Profit margin: 2.6% (up from 1.5% in FY 2019). The increase in margin was driven by higher revenue.모든 업데이트 보기Recent updatesBoard Change • 15hNo independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • May 11Making Science Group, S.A., Annual General Meeting, Jun 11, 2026Making Science Group, S.A., Annual General Meeting, Jun 11, 2026. Location: lopez de hoyos 135, 3, madrid., Spain공시 • Mar 25Making Science Group, S.A. announces Annual dividend, payable on April 30, 2026Making Science Group, S.A. announced Annual dividend of EUR 0.1799 per share payable on April 30, 2026, ex-date on April 28, 2026 and record date on April 29, 2026.공시 • Feb 17Making Science Group, S.A., Annual General Meeting, Mar 18, 2026Making Science Group, S.A., Annual General Meeting, Mar 18, 2026. Location: calle lopez de hoyos 135, 3., madrid SpainBoard Change • Dec 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • May 12Making Science Group, S.A., Annual General Meeting, Jun 12, 2025Making Science Group, S.A., Annual General Meeting, Jun 12, 2025. Location: calle lopez de hoyos 135, 3., madrid Spain공시 • Jan 09Making Science Launches RAISING, Its New AI Technology Division to Power Marketing StrategiesMaking Science has announced the launch of RAISING, its new technology division that combines the company's business expertise with data science to develop advanced solutions based on Artificial Intelligence. This new venture aims to transform brands' marketing strategies through predictive, generative, and automated AI technologies, optimizing results throughout the entire funnel. RAISING integrates cutting-edge tools that reinforce its technology proposition. These include ad-machina, Making Science's technology that uses generative AI to automate the creation and multi-platform activation of personalized ads in real-time. The tool has proven its effectiveness on platforms such as Performance Max and Meta, achieving up to 30% more conversions compared to traditional methods. Its advanced functionalalities allow the dynamic adaptation of text, image, or video ads to market and user needs, incorporating detailed data analysis, automatic translation, and large-scale optimization, ensuring more effective and profitable campaigns, which relevant companies such as Banco Santander or MediaMarkt have already integrated into their business plans. Another key product of this new division is Gauss AI, which is designed to predict user behavior and optimize distribution, measurement, and media planning strategies. This system helps companies to identify the most relevant and profitable interactions, increasing the effectiveness of their campaigns. Trust Generative AI is positioned as a versatile and secure tool for content generation at scale, automating internal and external processes in areas such as marketing, SEO, and human resources while ensuring regulatory compliance and ultimate human control. The launch of RAISING reinforces Making Science's position as a benchmark in technological innovation applied to marketing.공시 • Nov 19Making Science Announces Management ChangesMaking Science has announced the appointment of Nick Waters as CEO for the UK, Northern and Central Europe. Based in London, with extensive experience in business leadership and the technology market, Waters will be responsible for driving the company’s growth and expansion across Europe. Due to take up the role in February 2025, Waters brings over 20 years of experience in international media, digital, and advertising. He joins Making Science from Ebiquity Plc, where he was Group Chief Executive Officer. Before that, he spent 10 years at Dentsu Aegis Network – latterly as Executive Chairman UK & Ireland, and 12 years at Mindshare, rising to regional CEO of Europe, Middle East, and Africa. Waters’ appointment follows the announcement of Marcus Cooper as Business Director, UK, Brad Beiter as SVP of Customer Management, and José Luis Pulpón, (ex Google) as Managing Director for Making Science, Spain. These strategic hires play a vital role in Making Science’s global expansion to ensure the delivery of cutting-edge digital transformation solutions for its clients across industries.Reported Earnings • Oct 24Second quarter 2023 earnings releasedSecond quarter 2023 results: €0.12 loss per share. Revenue: €57.0m (up 15% from 2Q 2022). Net loss: €1.03m (loss widened 35% from 2Q 2022).New Risk • Jul 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (8.3% increase in shares outstanding). Market cap is less than US$100m (€69.6m market cap, or US$75.4m).공시 • May 21Making Science Group, S.A., Annual General Meeting, Jun 17, 2024Making Science Group, S.A., Annual General Meeting, Jun 17, 2024. Location: calle lopez de hoyos 135, 3., madrid SpainNew Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€74.2m market cap, or US$80.6m).New Risk • May 16New major risk - Revenue and earnings growthEarnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€74.4m market cap, or US$80.9m).New Risk • Apr 18New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Minor Risk Market cap is less than US$100m (€72.8m market cap, or US$77.7m).New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€91.0m market cap, or US$97.3m).New Risk • Nov 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€79.0m market cap, or US$84.7m).New Risk • Oct 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€69.0m market cap, or US$73.0m).Reported Earnings • Apr 20Full year 2022 earnings releasedFull year 2022 results: Revenue: €213.4m (up 89% from FY 2021). Net loss: €4.99m (loss widened 43% from FY 2021).Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €13.60, the stock trades at a trailing P/E ratio of 67x. Average trailing P/E is 19x in the Media industry in Germany. Total loss to shareholders of 45% over the past year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Sep 03Making Science Group, S.A. (BME:MAKS) acquired 51% stake in Agua3 Growth Engines.Making Science Group, S.A. (BME:MAKS) acquired 51% stake in Agua3 Growth Engines on September 2, 2021. Making Science reserves a purchase option on the remaining 49% stake in Agua3 Growth Engines. Making Science Group, S.A. (BME:MAKS) completed the acquisition of 51% stake in Agua3 Growth Engines on September 2, 2021.공시 • May 04Making Science Group, S.A. (BME:MAKS) acquired Ventis S.R.L. for €9.5 million.Making Science Group, S.A. (BME:MAKS) acquired Ventis S.R.L. for €9.5 million on May 3, 2021. Making Science Group, S.A. (BME:MAKS) completed the acquisition of Ventis S.R.L. on May 3, 2021.Reported Earnings • Apr 17Full year 2020 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €58.9m (up 130% from FY 2019). Net income: €1.54m (up 302% from FY 2019). Profit margin: 2.6% (up from 1.5% in FY 2019). The increase in margin was driven by higher revenue.Is New 90 Day High Low • Feb 27New 90-day high: €26.50The company is up 103% from its price of €13.05 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Media industry, which is up 17% over the same period.공시 • Feb 10Making Science Group, SA and its subsidiary Making Science Ltd, have acquired 100% stake in Nara Media Ltd., and 51% stake in Celsius SAS.Making Science Group, SA and its subsidiary Making Science Ltd, have acquired 100% stake in Nara Media Ltd., and 51% stake in Celsius SAS on February 8, 2021. The two companies are acquired debt free. The enterprise value agreed by Nara Media is €6.15 million and will be paid with a part in shares,another in cash and another in an earn-out. The purchase price of 51% of Celsius, SAS is €1 million down payment, 300,000 Making Science shares and an earn-out of €1.2 million. Making Science has secured a purchase option for the remaining 49% of Celsius, SAS.The two companies have generated a joint EBITDA of 1.7 million euros in 2020 Making Science Group, SA and its subsidiary Making Science Ltd, have completed the acquisition of100% stake in Nara Media Ltd., and 51% stake in Celsius SAS on February 8, 2021.Is New 90 Day High Low • Feb 10New 90-day high: €15.30The company is up 6.0% from its price of €14.40 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 18% over the same period.매출 및 비용 세부 내역Making Science Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:MS7 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25348-80030 Sep 25331-6-1030 Jun 25315-4-1031 Mar 25294-3-1031 Dec 24274-20030 Sep 2426401030 Jun 24251-12031 Mar 24244-22031 Dec 23236-41030 Sep 23230-3-3030 Jun 23225-1-7031 Mar 23217-1-4031 Dec 22210-10030 Sep 22187-27030 Jun 22165-413031 Mar 22139-411031 Dec 21113-39030 Sep 2198-2-23030 Jun 21830-11031 Mar 21711-4031 Dec 205923031 Dec 1935128031 Dec 185020양질의 수익: MS7 은(는) 현재 수익성이 없습니다.이익 마진 증가: MS7는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: MS7은 수익성이 없으며 지난 5년 동안 손실이 연평균 30.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 MS7의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: MS7은 수익성이 없어 지난 해 수익 성장률을 Media 업계(-11.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: MS7는 현재 수익성이 없으므로 자본 수익률이 음수(-17.07%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMedia 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 13:06종가2026/05/20 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Making Science Group, S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Oct 24Second quarter 2023 earnings releasedSecond quarter 2023 results: €0.12 loss per share. Revenue: €57.0m (up 15% from 2Q 2022). Net loss: €1.03m (loss widened 35% from 2Q 2022).
Reported Earnings • Apr 20Full year 2022 earnings releasedFull year 2022 results: Revenue: €213.4m (up 89% from FY 2021). Net loss: €4.99m (loss widened 43% from FY 2021).
Reported Earnings • Apr 17Full year 2020 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €58.9m (up 130% from FY 2019). Net income: €1.54m (up 302% from FY 2019). Profit margin: 2.6% (up from 1.5% in FY 2019). The increase in margin was driven by higher revenue.
Board Change • 15hNo independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • May 11Making Science Group, S.A., Annual General Meeting, Jun 11, 2026Making Science Group, S.A., Annual General Meeting, Jun 11, 2026. Location: lopez de hoyos 135, 3, madrid., Spain
공시 • Mar 25Making Science Group, S.A. announces Annual dividend, payable on April 30, 2026Making Science Group, S.A. announced Annual dividend of EUR 0.1799 per share payable on April 30, 2026, ex-date on April 28, 2026 and record date on April 29, 2026.
공시 • Feb 17Making Science Group, S.A., Annual General Meeting, Mar 18, 2026Making Science Group, S.A., Annual General Meeting, Mar 18, 2026. Location: calle lopez de hoyos 135, 3., madrid Spain
Board Change • Dec 30No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • May 12Making Science Group, S.A., Annual General Meeting, Jun 12, 2025Making Science Group, S.A., Annual General Meeting, Jun 12, 2025. Location: calle lopez de hoyos 135, 3., madrid Spain
공시 • Jan 09Making Science Launches RAISING, Its New AI Technology Division to Power Marketing StrategiesMaking Science has announced the launch of RAISING, its new technology division that combines the company's business expertise with data science to develop advanced solutions based on Artificial Intelligence. This new venture aims to transform brands' marketing strategies through predictive, generative, and automated AI technologies, optimizing results throughout the entire funnel. RAISING integrates cutting-edge tools that reinforce its technology proposition. These include ad-machina, Making Science's technology that uses generative AI to automate the creation and multi-platform activation of personalized ads in real-time. The tool has proven its effectiveness on platforms such as Performance Max and Meta, achieving up to 30% more conversions compared to traditional methods. Its advanced functionalalities allow the dynamic adaptation of text, image, or video ads to market and user needs, incorporating detailed data analysis, automatic translation, and large-scale optimization, ensuring more effective and profitable campaigns, which relevant companies such as Banco Santander or MediaMarkt have already integrated into their business plans. Another key product of this new division is Gauss AI, which is designed to predict user behavior and optimize distribution, measurement, and media planning strategies. This system helps companies to identify the most relevant and profitable interactions, increasing the effectiveness of their campaigns. Trust Generative AI is positioned as a versatile and secure tool for content generation at scale, automating internal and external processes in areas such as marketing, SEO, and human resources while ensuring regulatory compliance and ultimate human control. The launch of RAISING reinforces Making Science's position as a benchmark in technological innovation applied to marketing.
공시 • Nov 19Making Science Announces Management ChangesMaking Science has announced the appointment of Nick Waters as CEO for the UK, Northern and Central Europe. Based in London, with extensive experience in business leadership and the technology market, Waters will be responsible for driving the company’s growth and expansion across Europe. Due to take up the role in February 2025, Waters brings over 20 years of experience in international media, digital, and advertising. He joins Making Science from Ebiquity Plc, where he was Group Chief Executive Officer. Before that, he spent 10 years at Dentsu Aegis Network – latterly as Executive Chairman UK & Ireland, and 12 years at Mindshare, rising to regional CEO of Europe, Middle East, and Africa. Waters’ appointment follows the announcement of Marcus Cooper as Business Director, UK, Brad Beiter as SVP of Customer Management, and José Luis Pulpón, (ex Google) as Managing Director for Making Science, Spain. These strategic hires play a vital role in Making Science’s global expansion to ensure the delivery of cutting-edge digital transformation solutions for its clients across industries.
Reported Earnings • Oct 24Second quarter 2023 earnings releasedSecond quarter 2023 results: €0.12 loss per share. Revenue: €57.0m (up 15% from 2Q 2022). Net loss: €1.03m (loss widened 35% from 2Q 2022).
New Risk • Jul 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (8.3% increase in shares outstanding). Market cap is less than US$100m (€69.6m market cap, or US$75.4m).
공시 • May 21Making Science Group, S.A., Annual General Meeting, Jun 17, 2024Making Science Group, S.A., Annual General Meeting, Jun 17, 2024. Location: calle lopez de hoyos 135, 3., madrid Spain
New Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€74.2m market cap, or US$80.6m).
New Risk • May 16New major risk - Revenue and earnings growthEarnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€74.4m market cap, or US$80.9m).
New Risk • Apr 18New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Minor Risk Market cap is less than US$100m (€72.8m market cap, or US$77.7m).
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€91.0m market cap, or US$97.3m).
New Risk • Nov 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€79.0m market cap, or US$84.7m).
New Risk • Oct 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Market cap is less than US$100m (€69.0m market cap, or US$73.0m).
Reported Earnings • Apr 20Full year 2022 earnings releasedFull year 2022 results: Revenue: €213.4m (up 89% from FY 2021). Net loss: €4.99m (loss widened 43% from FY 2021).
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €13.60, the stock trades at a trailing P/E ratio of 67x. Average trailing P/E is 19x in the Media industry in Germany. Total loss to shareholders of 45% over the past year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Sep 03Making Science Group, S.A. (BME:MAKS) acquired 51% stake in Agua3 Growth Engines.Making Science Group, S.A. (BME:MAKS) acquired 51% stake in Agua3 Growth Engines on September 2, 2021. Making Science reserves a purchase option on the remaining 49% stake in Agua3 Growth Engines. Making Science Group, S.A. (BME:MAKS) completed the acquisition of 51% stake in Agua3 Growth Engines on September 2, 2021.
공시 • May 04Making Science Group, S.A. (BME:MAKS) acquired Ventis S.R.L. for €9.5 million.Making Science Group, S.A. (BME:MAKS) acquired Ventis S.R.L. for €9.5 million on May 3, 2021. Making Science Group, S.A. (BME:MAKS) completed the acquisition of Ventis S.R.L. on May 3, 2021.
Reported Earnings • Apr 17Full year 2020 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €58.9m (up 130% from FY 2019). Net income: €1.54m (up 302% from FY 2019). Profit margin: 2.6% (up from 1.5% in FY 2019). The increase in margin was driven by higher revenue.
Is New 90 Day High Low • Feb 27New 90-day high: €26.50The company is up 103% from its price of €13.05 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Media industry, which is up 17% over the same period.
공시 • Feb 10Making Science Group, SA and its subsidiary Making Science Ltd, have acquired 100% stake in Nara Media Ltd., and 51% stake in Celsius SAS.Making Science Group, SA and its subsidiary Making Science Ltd, have acquired 100% stake in Nara Media Ltd., and 51% stake in Celsius SAS on February 8, 2021. The two companies are acquired debt free. The enterprise value agreed by Nara Media is €6.15 million and will be paid with a part in shares,another in cash and another in an earn-out. The purchase price of 51% of Celsius, SAS is €1 million down payment, 300,000 Making Science shares and an earn-out of €1.2 million. Making Science has secured a purchase option for the remaining 49% of Celsius, SAS.The two companies have generated a joint EBITDA of 1.7 million euros in 2020 Making Science Group, SA and its subsidiary Making Science Ltd, have completed the acquisition of100% stake in Nara Media Ltd., and 51% stake in Celsius SAS on February 8, 2021.
Is New 90 Day High Low • Feb 10New 90-day high: €15.30The company is up 6.0% from its price of €14.40 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Media industry, which is up 18% over the same period.